FDA draft guidance
Also: Blockchain for clinical trials; Peloton's upcoming IPO.
The FDA has, at long last, released draft guidance for how pharmaceutical companies should behave on limited-character social media platforms like Twitter and when correcting misinformation on third-party sites.